Agonist activity of sumatriptan and metergoline at the human 5-HT1Dβ receptor: further evidence for a role of the 5-HT1D receptor in the action of sumatriptan
- 1 September 1992
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 227 (1), 99-102
- https://doi.org/10.1016/0922-4106(92)90149-p
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Mode of action of the anti-migraine drug sumatriptanTrends in Pharmacological Sciences, 1991
- Molecular Biology of Serotonin ReceptorsAnnual Review of Neuroscience, 1991
- Vascular 5‐HT1‐like receptors that mediate contraction of the dog isolated saphenous vein and carotid arterial vasoconstriction in anaesthetized dogs are not of the 5‐HT1A or 5‐HT1D subtypeBritish Journal of Pharmacology, 1991
- 5-Hydroxytryptamine 5-HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase activityNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1989
- How selective is GR 43175? Interactions with functional 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptorsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1989
- POSSIBLE BENEFIT OF GR43175, A NOVEL 5-HT1-LIKE RECEPTOR AGONIST, FOR THE ACUTE TREATMENT OF SEVERE MIGRAINEThe Lancet, 1988